D
Dechra Pharmaceuticals PLC
F:1PK
Dechra Pharmaceuticals PLC
F:1PK
Price:
45.2
EUR
Market Closed
Market Cap:
€5.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
UK |
|
A
|
AIM Industrial Growth Freehold and Leasehold Real Estate Investment Trust
SET:AIMIRT
|
TH |
|
Sonos Inc
NASDAQ:SONO
|
US |
|
Discover Financial Services
NYSE:DFS
|
US |
|
D
|
Deere & Co
XBER:DCO
|
US |
|
W
|
Wilmar International Ltd
OTC:WLMIY
|
SG |
|
E
|
Ekso Bionics Holdings Inc
F:23E2
|
US |
|
I
|
Intel Corp
XMUN:INL
|
US |
|
Solstad Maritime ASA
F:O6O
|
NO |
|
Puradelta Lestari Tbk PT
IDX:DMAS
|
ID |
|
Mesoblast Ltd
ASX:MSB
|
AU |
|
Sanlorenzo SpA
MIL:SL
|
IT |
|
F
|
Freeport-McMoRan Inc
BMV:FCX
|
US |
|
Telefonica SA
MAD:TEF
|
ES |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1PK's stock price target?
Not Available
1PK does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Dechra Pharmaceuticals PLC?
Projected CAGR
9%
9%
Over the last 8 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Dechra Pharmaceuticals PLC?
Projected CAGR
98%
98%
Over the last 8 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 3 years is 98%.
